NCT01113476 2022-09-02Nab-paclitaxel, Gemcitabine, and Bevacizumab in Advanced MalignanciesM.D. Anderson Cancer CenterPhase 1 Completed176 enrolled
NCT02383212 2020-01-27Study of REGN2810 (Anti-PD-1) in Patients With Advanced MalignanciesRegeneron PharmaceuticalsPhase 1 Completed398 enrolled